atezolizumab,bevacizumab
roche
['gyn', 'ovarian', 'platinum']
immune checkpoint inhibition disappoints in relapsed platinum-sensitive ovarian cancer #ovca #esmo22 #gyncsm 
A/Prof UNSW. Border Medical Oncology Albury Wodonga Regional Cancer Centre @AWRCCentre PCPA President https://t.co/soCid5JOE5 SIOG, ASCO, COSA, MOGA, MASCC, IGCS